Global Continuous Glucose Monitoring Systems Market Set for Unprecedented Growth, Projected to Reach USD 103.5 Billion by 2033

Posted on 2024-09-17 by Future Market Insights in Healthcare, Pharmaceuticals // 0 Comments

The global continuous glucose monitoring systems market is poised for extraordinary growth, as recent reports reveal a significant surge in market value. From an estimated USD 11.1 billion in 2023, the CGM market is expected to skyrocket to an impressive USD 103.5 billion by 2033, driven by a compound annual growth rate (CAGR) of 25.1%. This rapid expansion underscores the growing importance of CGM systems in the management of diabetes.

The rising prevalence of diabetes worldwide and the superior capabilities of CGM systems compared to traditional fingerstick glucose tests are the primary forces behind this growth. Unlike conventional methods, which provide glucose readings at specific moments, CGM systems offer continuous, real-time monitoring of blood glucose levels 24/7. This real-time insight allows users to make timely decisions, resulting in more effective glycemic control and better overall diabetes management.

The cutting-edge technology embedded in CGM systems provides comprehensive data that enhances the quality of life for individuals living with diabetes. By transcending the limitations of traditional glucose testing, CGM systems empower users with greater control over their health, ultimately leading to improved health outcomes.

As the market continues to expand, the adoption of CGM systems is expected to accelerate rapidly. This trend highlights the critical role of CGM technology in shaping the future of diabetes care. The shift towards continuous glucose monitoring represents a transformative leap forward in diabetes management, offering patients around the world unprecedented levels of control, insight, and health benefits.

Key Takeaways:

The global CGM systems market is set to grow from USD 11.1 billion in 2023 to an estimated USD 103.5 billion by 2033, reflecting a CAGR of 25.1%.
The rising prevalence of diabetes worldwide and increasing awareness about the benefits of CGM systems are the primary drivers of this growth.
The Asia Pacific region is anticipated to experience the fastest market expansion, driven by a burgeoning diabetic population and improving healthcare systems.
The growing geriatric population, increasing demand for better diabetes diagnostics, and the need to address unmet healthcare needs, particularly in developing regions, are also contributing to market growth.

Explore the High Demand for Continuous Glucose Monitoring Systems: Our Full Report Provides a Detailed Look at Emerging Trends!

Leading Market Players:

Prominent players driving the CGM systems market forward include Abbott, Herbalife Nutrition, GNC Holdings, NOW Health, and Nutramax Laboratories, among others. These companies are at the forefront of innovation, ensuring that CGM systems continue to evolve and meet the growing needs of the global diabetic population.

Market Segmentation:

By Components:

Transmitters and Monitors
Sensors
Insulin Pumps

By End-use Sector:

Home Care Diagnostics
Hospitals
ICU/Critical Care

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick